Navigation Links
Pwo DNA Polymerase

for routine high fidelity amplification of up to 3.5 kb DNA targets Cat. No. 1 664 947 100 units
Cat. No. 1 664 955 2 x 250 units Description Pwo DNA polymerase was originally isolated from hyperthermophilic archaebacterium Pyrococcus woesei. The enzyme has a molecular weight of about 90 kD. It is a highly processive 5'3' DNA polymerase and possesses an 3'5' exonuclease activity also known as proofreading activity. The enzyme has no detectable 5'3' exonuclease activity. Pwo DNA polymerase exhibits increased thermal stability with a half life of greater than 2 h at 100C compared to Taq DNA polymerase with a half life of less than 5 min at this temperature. The inherent 3'5' exonuclease proofreading activity Pwo results in an over 18-fold increased fidelity of DNA synthesis compared to Taq DNA polymerase. Pwo DNA polymerase generated PCR products are blunt-ended and can therefore be used directly for blunt-end ligation without any pretreatment of the ends. For further information please download the Pwo DNA Polymerase
pack insert
. Application Fidelity of in vitro DNA polymerization is one of the most important subjects in PCR. For many applications of PCR, where a homogenous DNA population is analyzed (i.e. direct sequencing or restriction endonu-clease digestion), the mutations that are induced by the polymerase during PCR are of little concern. However if only a small amount of template DNA or RNA is used as starting mat erial and if after PCR single DNA molecules are analyzed, PCR artifacts can be a significant problem. Fidelity of DNA polymerization is for instance important for:
  • cloning of PCR products
  • study of allelic polymorphism in individual RNA transcripts (1, 2)
  • characterisation of the allelic stage of single cells (3) or single DNA molecules (4, 5)
  • characterisation of rare mutations in tissue (6)
  • characterisation of a population of cells in culture
Operating parameters
  • Thermal stability: Pwo DNA Polymerase is stable for >2 h at 95C
  • Divalent ion requirement: Mg2+ (standard concentration, 2.00 mM)
  • dNTP concentration: at least 200 M for each dNTP
    Caution: Lower deoxynucleotide concentrations can increase fidelity but can also activate the 3'5' exonuclease proofreading activity, which might degrade prime
Experimental results Key advantages
  • Maximum PCR fidelity, because the proofreading activity of Pwo DNA Polymerase excises misincorporated nucleotides
  • High PCR yield, because the polymerase is very resistant to the high denaturing temperatures used in PCR
  • Simplifies cloning of PCR products because it generates blunt-ended products which can be directly used f or blunt-end ligation
Note: Pwo DNA Polymerase cannot amplify targets longer than approx. 3.5 kb. For high fidelity amplification of longer templates use one of the Expand PCR Systems.
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
2. Pfu DNA Polymerase as a Hot Start Alternative
3. PCR Performance Comparisons Between pfuturbo and Taq DNA Polymerases
4. pfuturbo DNA Polymerase: A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning
5. Unique DNA Polymerase Formulation Excels in a Broad Range of PCR Applications
6. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
7. High-Fidelity PCR with a Novel Polymerase Mixture
8. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
9. Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR Performance
10. The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated DNA
11. HotStarTaq DNA Polymerase
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology:
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):